Skip to main content

Venetoclax

Meaning

Venetoclax is a highly targeted, small-molecule chemotherapy drug classified as a BCL-2 inhibitor, primarily used in the clinical treatment of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Its mechanism of action is to selectively induce apoptosis, or programmed cell death, in cancer cells that rely on the BCL-2 protein for survival. While not a direct hormonal therapy, its use is relevant in the health and longevity space as an example of precision medicine targeting cell survival pathways.